|
Summary Information: Eiger BioPharmaceuticals Inc. Common Stock NASDAQ:EIGR |
admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Eiger is a commercial-stage biopharmaceutical company focused on the development and commercialization of foundational therapies for Hepatitis Delta Virus (HDV) infection, the most serious form of human viral hepatitis.
__The following are links to various summary and news pages for __Eiger BioPharmaceuticals Inc. Common Stock [ EIGR ]. __Note: Some Links might not have information for the company. |
|